CIBC ASSET MANAGEMENT INC Revance Therapeutics, Inc. Transaction History

CIBC ASSET MANAGEMENT INC portfolio value:

$13.53M
portfolio value

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 501.16K shares 13.53M $27 501.16K
Q2 2022 share Decrease -100.00% -470.81K shares -9.18M $13.82 0
Q1 2022 share Decrease -5.50% -27.41K shares 1.05M $19.5 470.81K
Q4 2021 share Increase 0.00% 498.22K shares 8.13M $16.49 498.22K